Showing 21 - 40 results of 184 for search '"facioscapulohumeral muscular dystrophy"', query time: 0.15s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24

    Upper Limb Rehabilitation in Facioscapulohumeral Muscular Dystrophy: A Patients’ Perspective by Alice Faux-Nightingale, MPhil, Richa Kulshrestha, MRCPCH, Nicholas Emery, PGDip, Anand Pandyan, PhD, Tracey Willis, MD, Fraser Philp, PhD

    Published 2021-12-01
    “…Objective: To identify (1) what exercise modalities people living with facioscapulohumeral muscular dystrophy (FSHD) are undertaking in the community as a part of their ongoing rehabilitation and (2) what future research projects would gain the support of people with FSHD. …”
    Get full text
    Article
  5. 25

    Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review by Tai-Heng Chen, Yan-Zhang Wu, Yung-Hao Tseng

    Published 2020-10-01
    Subjects: “…facioscapulohumeral muscular dystrophy…”
    Get full text
    Article
  6. 26
  7. 27

    Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges by Stephanie Efthymiou, Richard J. L. F. Lemmers, Venugopalan Y. Vishnu, Natalia Dominik, Benedetta Perrone, Stefano Facchini, Elisa Vegezzi, Sabrina Ravaglia, Lindsay Wilson, Patrick J. van der Vliet, Rinkle Mishra, Alisha Reyaz, Tanveer Ahmad, Rohit Bhatia, James M. Polke, Mv Padma Srivastava, Andrea Cortese, Henry Houlden, Silvère M. van der Maarel, Michael G. Hanna, Enrico Bugiardini

    Published 2023-10-01
    “…Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy in adults, and it is associated with local D4Z4 chromatin relaxation, mostly via the contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. …”
    Get full text
    Article
  8. 28
  9. 29
  10. 30

    Acupuncture Improves the Facial Muscular Function in a Case of Facioscapulohumeral Muscular Dystrophy by Yutan Liu, Fei Xiao, Xibin Liang

    Published 2019-04-01
    “…Facioscapulohumeral muscular dystrophy (FSHD) is a genetic muscle disorder in which muscles of the face, shoulder blades, and upper arms develop gradual and progressive weakness. …”
    Get full text
    Article
  11. 31
  12. 32
  13. 33

    Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. by Giorgio Tasca, Mario Pescatori, Mauro Monforte, Massimiliano Mirabella, Elisabetta Iannaccone, Roberto Frusciante, Tiziana Cubeddu, Francesco Laschena, Pierfrancesco Ottaviani, Enzo Ricci

    Published 2012-01-01
    “…BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common muscular dystrophies and is characterized by a non-conventional genetic mechanism activated by pathogenic D4Z4 repeat contractions. …”
    Get full text
    Article
  14. 34
  15. 35

    Correlation analysis between genotype and phenotype of patients with facioscapulohumeral muscular dystrophy type 1 by Huan LI, Qiu CHEN, Jin-fu LIN, Zi-yu LIAO, Liang WANG, Jing LI, Yu-ling ZHU, Cheng ZHANG

    Published 2019-05-01
    “…Objective To investigate the clinical phenotype and genotype of facioscapulohumeral muscular dystrophy type 1 (FSHD1) and the correlation between the two. …”
    Get full text
    Article
  16. 36
  17. 37

    PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle by Christopher R. S. Banerji, Maryna Panamarova, Husam Hebaishi, Robert B. White, Frédéric Relaix, Simone Severini, Peter S. Zammit

    Published 2017-12-01
    “…Facioscapulohumeral muscular dystrophy is a myopathy linked to ectopic expression of the DUX4 transcription factor. …”
    Get full text
    Article
  18. 38

    Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients by Lorena Di Pietro, Flavia Giacalone, Elvira Ragozzino, Valentina Saccone, Federica Tiberio, Marco De Bardi, Mario Picozza, Giovanna Borsellino, Wanda Lattanzi, Enrico Guadagni, Sara Bortolani, Giorgio Tasca, Enzo Ricci, Ornella Parolini

    Published 2022-09-01
    “…These cells have recently emerged as remarkable therapeutic targets for neuromuscular disorders, although to date they have been poorly investigated in facioscapulohumeral muscular dystrophy (FSHD). In this study, we characterised the non-myogenic mesenchymal stromal cell population in FSHD patients’ muscles with signs of disease activity, identified by muscle magnetic resonance imaging (MRI), and compared them with those obtained from apparently normal muscles of FSHD patients and from muscles of healthy, age-matched controls. …”
    Get full text
    Article
  19. 39
  20. 40